These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 9305678)
41. Hepatic iron stainings in chronic hepatitis C patients with low HCV RNA levels: a predictive marker for IFN therapy. Akiyoshi F; Sata M; Uchimura Y; Suzuki H; Tanikawa K Am J Gastroenterol; 1997 Sep; 92(9):1463-6. PubMed ID: 9317063 [TBL] [Abstract][Full Text] [Related]
42. Effect of iron depletion on long-term response to interferon-alpha in patients with chronic hepatitis C who previously did not respond to interferon therapy. Tsai NC; Zuckerman E; Han SH; Goad K; Redeker AG; Fong TL Am J Gastroenterol; 1997 Oct; 92(10):1831-4. PubMed ID: 9382046 [TBL] [Abstract][Full Text] [Related]
43. Sequential versus concomitant administration of ribavirin and interferon alfa-n3 in patients with chronic hepatitis C not responding to interferon alone: results of a randomized, controlled trial. Sostegni R; Ghisetti V; Pittaluga F; Marchiaro G; Rocca G; Borghesio E; Rizzetto M; Saracco G Hepatology; 1998 Aug; 28(2):341-6. PubMed ID: 9695995 [TBL] [Abstract][Full Text] [Related]
44. Factors predictive of a beneficial response to therapy of hepatitis C. Davis GL; Lau JY Hepatology; 1997 Sep; 26(3 Suppl 1):122S-127S. PubMed ID: 9305676 [TBL] [Abstract][Full Text] [Related]
45. Biochemical, virological and histopathological changes in Danish blood donors with antibodies to hepatitis C virus. Grønbaek KE; Jensen OJ; Krarup HB; Dietrichson O Dan Med Bull; 1996 Apr; 43(2):186-8. PubMed ID: 8741210 [TBL] [Abstract][Full Text] [Related]
46. Treatment of hepatitis C patients with normal aminotransferases levels. Marcellin P; Martinot M; Boyer N; Lévy S Clin Liver Dis; 1999 Nov; 3(4):843-53. PubMed ID: 11291254 [TBL] [Abstract][Full Text] [Related]
47. Nucleotide sequence variation in the hypervariable region of the hepatitis C virus in the sera of chronic hepatitis C patients undergoing controlled interferon-alpha therapy. Yeh BI; Han KH; Oh SH; Kim HS; Hong SH; Oh SH; Kim YS J Med Virol; 1996 Jun; 49(2):95-102. PubMed ID: 8991943 [TBL] [Abstract][Full Text] [Related]
48. Assessment of liver histology in patients with hepatitis C and normal transaminase levels. Stanley AJ; Haydon GH; Piris J; Jarvis LM; Hayes PC Eur J Gastroenterol Hepatol; 1996 Sep; 8(9):869-72. PubMed ID: 8889452 [TBL] [Abstract][Full Text] [Related]
49. Increased serum hepatitis C virus RNA levels among alcoholic patients with chronic hepatitis C. Oshita M; Hayashi N; Kasahara A; Hagiwara H; Mita E; Naito M; Katayama K; Fusamoto H; Kamada T Hepatology; 1994 Nov; 20(5):1115-20. PubMed ID: 7523270 [TBL] [Abstract][Full Text] [Related]
50. Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy. Marcellin P; Boyer N; Gervais A; Martinot M; Pouteau M; Castelnau C; Kilani A; Areias J; Auperin A; Benhamou JP; Degott C; Erlinger S Ann Intern Med; 1997 Nov; 127(10):875-81. PubMed ID: 9382365 [TBL] [Abstract][Full Text] [Related]
51. The role of liver biopsy in hepatitis C. Perrillo RP Hepatology; 1997 Sep; 26(3 Suppl 1):57S-61S. PubMed ID: 9305665 [TBL] [Abstract][Full Text] [Related]
52. Hepatitis C in asymptomatic blood donors. Alter HJ; Conry-Cantilena C; Melpolder J; Tan D; Van Raden M; Herion D; Lau D; Hoofnagle JH Hepatology; 1997 Sep; 26(3 Suppl 1):29S-33S. PubMed ID: 9305660 [TBL] [Abstract][Full Text] [Related]
53. Treatment of patients with chronic hepatitis C and normal ALT levels. Tassopoulos NC J Hepatol; 1999; 31 Suppl 1():193-6. PubMed ID: 10622586 [TBL] [Abstract][Full Text] [Related]
54. Effect of interferon administration on serum hepatitis C virus RNA in patients with chronic hepatitis C. Chayama K; Saitoh S; Arase Y; Ikeda K; Matsumoto T; Sakai Y; Kobayashi M; Unakami M; Morinaga T; Kumada H Hepatology; 1991 Jun; 13(6):1040-3. PubMed ID: 1711001 [TBL] [Abstract][Full Text] [Related]
55. Serum hepatitis C virus RNA quantity and histological features of hepatitis C virus carriers with persistently normal ALT levels. Naito M; Hayashi N; Hagiwara H; Hiramatsu N; Kasahara A; Fusamoto H; Kamada T Hepatology; 1994 Apr; 19(4):871-5. PubMed ID: 8138259 [TBL] [Abstract][Full Text] [Related]
56. Use of interferon in the treatment of chronic viral hepatitis. Gibas AL Gastroenterologist; 1993 Jun; 1(2):129-42. PubMed ID: 8049886 [TBL] [Abstract][Full Text] [Related]
57. [Histological assessment of the liver long after interferon treatment in patients with chronic type C hepatitis]. Yokosuka O; Hosoda K; Omata M Nihon Rinsho; 1994 Jul; 52(7):1841-6. PubMed ID: 7521428 [TBL] [Abstract][Full Text] [Related]
58. HCV carriers with normal alanine aminotransferase levels: healthy persons or severely ill patients? Dealing with an everyday clinical problem. Puoti C; Bellis L; Guarisco R; Dell' Unto O; Spilabotti L; Costanza OM Eur J Intern Med; 2010 Apr; 21(2):57-61. PubMed ID: 20206870 [TBL] [Abstract][Full Text] [Related]
59. Interferon alfa treatment of HCV RNA carriers with persistently normal transaminase levels: a pilot randomized controlled study. Sangiovanni A; Morales R; Spinzi G; Rumi M; Casiraghi A; Ceriani R; Colombo E; Fossati M; Prada A; Tavani E; Minoli G Hepatology; 1998 Mar; 27(3):853-6. PubMed ID: 9500717 [TBL] [Abstract][Full Text] [Related]
60. Treatment of chronic hepatitis C with a-interferon: an analysis of the literature. Niederau C; Heintges T; Häussinger D Hepatogastroenterology; 1996; 43(12):1544-56. PubMed ID: 8975964 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]